Variables | Squamous Cell | Non-Squamous Cell | ||
---|---|---|---|---|
Hazard Ratio | p-value | Hazard Ratio | p-value | |
Age | ||||
 ≤54 | 1 [Reference] | – | 1 [Reference] | – |
 55–64 | 1.105 | 0.778 | 1.313 | 0.154 |
 65–74 | 1.353 | 0.377 | 1.467 | 0.054 |
 ≥75 | 2.342 | 0.006 | 2.165 | < 0.001 |
Sex | ||||
 Female | 1 [Reference] | – | 1 [Reference] | – |
 Male | 0.987 | 0.949 | 1.051 | 0.723 |
Race | ||||
 White | 1 [Reference] | – | 1 [Reference] | – |
 Black | 0.871 | 0.768 | 1.162 | 0.443 |
 Hispanic | 1.908 | 0.113 | 0.462 | 0.091 |
 Asian/Pacific Islander | 2.007 | 0.148 | 0.386 | 0.184 |
 Other/Unknown | 0.000 | 1.000 | 1.628 | 0.351 |
Charlson/Deyo Score | ||||
 0 | 1 [Reference] | – | 1 [Reference] | – |
 1 | 1.406 | 0.093 | 1.430 | 0.046 |
 ≥2 | 1.569 | 0.153 | 2.395 | 0.001 |
Pathologic T Stage | ||||
 1 | 1 [Reference] | – | 1 [Reference] | – |
 2 | 1.798 | 0.070 | 1.583 | 0.127 |
 3 | 1.791 | 0.059 | 2.998 | < 0.001 |
 4 | 2.781 | 0.001 | 3.268 | < 0.001 |
Pathologic N Stage | ||||
 1 | 1 [Reference] | – | 1 [Reference] | – |
 2 | 1.403 | 0.077 | 1.261 | 0.144 |
 3 | 0.876 | 0.897 | 0.565 | 0.443 |
Grade | ||||
 Low | 1 [Reference] | – | 1 [Reference] | – |
 Intermediate | 1.090 | 0.824 | 1.554 | 0.320 |
 High | 0.719 | 0.389 | 2.786 | 0.009 |
 Unknown | 0.617 | 0.306 | 2.471 | 0.028 |
Surgical Margins | ||||
 Negative | 1 [Reference] | – | 1 [Reference] | – |
 Positive | 1.350 | 0.086 | 1.093 | 0.505 |
Radiotherapy | ||||
 Not Administered | 1 [Reference] | – | 1 [Reference] | – |
 Administered | 0.559 | 0.005 | 0.622 | 0.003 |
Chemotherapy | ||||
 Not Administered | 1 [Reference] | – | 1 [Reference] | – |
 Administered | 0.779 | 0.236 | 1.309 | 0.064 |
ECE Status | ||||
 Negative | 1 [Reference] | – | 1 [Reference] | – |
 Positive | 1.449 | 0.042 | 1.000 | 0.998 |